NEUROPACE, INC. Increase (Decrease) in Inventories
NEUROPACE, INC. (NPCE) reported Increase (Decrease) in Inventories of $1.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-11
- NEUROPACE, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $1.49M, a 47.25% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$125.00K, a 151.44% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$1.22M, a 190.31% decline year-over-year.
- NEUROPACE, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.84M, a 121.74% increase year-over-year.
- NEUROPACE, INC. increase (decrease) in inventories for fiscal 2025 was $3.67M, a 51.90% increase from fiscal 2024.
- NEUROPACE, INC. increase (decrease) in inventories for fiscal 2024 was $2.42M, a 42.40% increase from fiscal 2023.
- NEUROPACE, INC. increase (decrease) in inventories for fiscal 2023 was $1.70M, a 20.39% decline from fiscal 2022.
- NEUROPACE, INC. increase (decrease) in inventories for fiscal 2022 was $2.13M, a 84.52% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.36M 10-Q · filed 2026-08-11 | $139.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.98M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$125.00K 10-Q · filed 2026-05-12 | -$1.35M derived: sum of 2 quarters · filed 2026-05-12 | $490.00K derived: sum of 3 quarters · filed 2026-05-12 | $3.31M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $615.00K derived: sum of 2 quarters · filed 2026-03-03 | $3.43M derived: sum of 3 quarters · filed 2026-08-11 | $3.67M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.65M derived: sum of 2 quarters · filed 2026-08-11 | $4.89M 10-Q · filed 2025-11-04 | $6.25M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.06M 10-Q · filed 2026-08-11 | $4.41M derived: sum of 3 quarters · filed 2026-08-11 | $5.24M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $243.00K 10-Q · filed 2026-05-12 | $1.59M derived: sum of 2 quarters · filed 2026-05-12 | $2.42M derived: sum of 3 quarters · filed 2026-05-12 | $2.41M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.18M derived: sum of 2 quarters · filed 2026-03-03 | $2.17M derived: sum of 3 quarters · filed 2026-03-03 | $2.42M 10-K · filed 2026-03-03 |
| 2024-09-30 | $828.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $817.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.07M 10-Q · filed 2025-11-04 | $2.58M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $238.00K 10-Q · filed 2025-08-12 | $1.76M derived: sum of 3 quarters · filed 2025-08-12 | $1.55M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $249.00K 10-Q · filed 2025-05-13 | $1.77M derived: sum of 2 quarters · filed 2025-05-13 | $1.56M derived: sum of 3 quarters · filed 2025-05-13 | $875.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $1.31M derived: sum of 2 quarters · filed 2025-03-04 | $626.00K derived: sum of 3 quarters · filed 2025-03-04 | $1.70M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$893.00K derived: sum of 2 quarters · filed 2024-11-12 | $179.00K 10-Q · filed 2024-11-12 | $1.35M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$683.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $389.00K 10-Q · filed 2024-08-13 | $1.56M derived: sum of 3 quarters · filed 2024-08-13 | $1.76M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.07M 10-Q · filed 2024-05-08 | $2.24M derived: sum of 2 quarters · filed 2024-05-08 | $2.44M derived: sum of 3 quarters · filed 2024-05-08 | $2.84M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.37M derived: sum of 2 quarters · filed 2024-03-05 | $1.77M derived: sum of 3 quarters · filed 2024-03-05 | $2.13M 10-K · filed 2024-03-05 |
| 2022-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $602.00K derived: sum of 2 quarters · filed 2023-11-06 | $964.00K 10-Q · filed 2023-11-06 | $1.68M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $404.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $766.00K 10-Q · filed 2023-08-08 | $1.48M derived: sum of 3 quarters · filed 2023-08-08 | $1.70M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $362.00K 10-Q · filed 2023-05-04 | $1.08M derived: sum of 2 quarters · filed 2023-05-04 | $1.30M derived: sum of 3 quarters · filed 2023-05-04 | $1.36M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $718.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $938.00K derived: sum of 2 quarters · filed 2023-03-02 | $999.00K derived: sum of 3 quarters · filed 2023-03-02 | $1.16M 10-K · filed 2023-03-02 |
| 2021-09-30 | $220.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $281.00K derived: sum of 2 quarters · filed 2022-11-08 | $438.00K 10-Q · filed 2022-11-08 | $662.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $218.00K 10-Q · filed 2022-08-11 | $442.00K derived: sum of 3 quarters · filed 2022-08-11 | $242.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $157.00K 10-Q · filed 2022-05-12 | $381.00K derived: sum of 2 quarters · filed 2022-05-12 | $181.00K derived: sum of 3 quarters · filed 2022-05-12 | -$166.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $24.00K derived: sum of 2 quarters · filed 2022-03-10 | -$323.00K derived: sum of 3 quarters · filed 2022-03-10 | -$672.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$547.00K derived: sum of 2 quarters · filed 2021-11-10 | -$896.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$696.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$349.00K 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |